NF2 and meningioma: Despite the identification of NF2 mutations or loss of function, recent sequencing studies also revealed mutations involving TRAF7, KLF4, AKT1, SMO, POLR2A, and the ARID1A and TERT promoters of in meningiomas (3–6).